ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOGIPUZKOA
- Country
- Spain
- Type
- Beneficiary
- Website
- www.biodonostia.org
- Grants received
- 15
Funding record
- 15 grants on record
- €5,105,316.02 awarded in total
- 2010–2026 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Horizon Europe Framework Programme
- Seventh Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
8 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
- Servicio Vasco de Salud Osakidetza
- AARHUS UNIVERSITET
- AJL OHPTHALMIC S.A.
- ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOARABA
- ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOBIZKAIA
- FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Calls from this organisation
No published calls from this organisation.
Grants received
- Unraveling the impact of RNA-editing in neurodegeneration: a focus on TDP-43 related frontotemporal dementia.
- Boosting future REsearchers in biomaterials for Advanced healTH solutions
- Self-disinfecting, smart microfilms for healthcare & community acquired infections
- Engineering cancer dormancy as a collective emergent phenomenon: from matrix-enabled dormancy to collective dormancy-on-a-chip
- Circular DNA in diagnosis and disease models
- A modular strategy for the repair of critical sized bone fractures
- European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development
- A testing bed for the development of high-risk medical devices
- EUROlinkCAT: Establishing a linked European Cohort of Children with Congenital Anomalies
- Antimicrobial FLEXible POLymers for its use in hospital environments
- I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly
- Role of SOX9-BMI1 in adult neural stem cells and in glioma stem cells
- A New GEnetic LABoratory for non-invasive prenatal diagnosis
- EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations
- Development of a strategy to treat limb-girdle muscular dystrophy (LGMD2A) using combined cell and gene therapy strategies
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.